FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · The FTC alleges that the three PBMs created a perverse drug rebate system that prioritizes high rebates from drug manufacturers, leading to artificially inflated insulin list prices.
FTC Releases Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
Federal Trade Commission sues largest drug middlemen for
Sep 20, 2024 · The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted ...
Federal Trade Commission accuses three drug middlemen of …
Sep 21, 2024 · Federal Trade Commission accuses three drug middlemen of inflating insulin prices. In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system...
FTC Deepens Inquiry into Prescription Drug Middlemen
May 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued compulsory orders to two group purchasing organizations (GPOs) that negotiate drug rebates on behalf of other PBMs.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
Sep 20, 2024 · The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and...
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
Jul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug...
Federal Trade Commission to sue drug middlemen over prices …
Jul 10, 2024 · The Federal Trade Commission is planning to sue three large U.S. health companies over their practices as middlemen who negotiate prices for medications such as insulin, as the agency...
FTC sues drug middlemen for allegedly inflating insulin prices
Sep 20, 2024 · The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen use practices that boost their profits while...
FTC Sues Drug Middlemen Over Manipulating Insulin Market
Sep 20, 2024 · The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that...